Skip to main content
Quest Diagnostics

Reducing transfusion costs with patient blood management

Patient Blood Management (PBM) programs offer significant financial benefits for hospitals and health systems. Studies indicate that up to 40% of blood transfusions are unnecessary, leading to approximately $1.9 billion in direct costs and an additional $6.1 billion in avoidable adverse events annually in the US. Implementing a PBM program can reduce transfusion-related costs by up to 30% over 3 years, while also improving patient outcomes and reducing hospital stays.

Complete the form to the right to watch the webinar hosted by Quest Diagnostics and the American College of Healthcare Executives, where experts discuss strategic approaches to reducing costs, managing blood supply, an enhancing patient care.

Access the full article: Reduce unnecessary spend and drive efficiency

815

* indicates required

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.